PR Newswire
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 8 October 2024 was 1098.87p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
09 October 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 7 October 2024 was 1102.79p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
08 October 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 4 October 2024 was 1120.10p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
07 October 2024
For immediate release
04 October 2024
THE BIOTECH GROWTH TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 18 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 4,929,790 that a market total of 104,300 Ordinary shares of 25p each in the capital of the Company were purchased today for cancellation by the Company at a price of 1023.89 pence per share.
Following this transaction, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 31,859,679. The Company does not currently hold any Ordinary shares in treasury.
The figure of 31,859,679 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Katherine Manson
Frostrow Capital LLP
Tel: 020 3709 8734
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 3 October 2024 was 1094.91p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
04 October 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 2 October 2024 was 1113.01p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
03 October 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 1 October 2024 was 1113.93p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
02 October 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 30 September 2024 was 1107.75p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
01 October 2024
The Biotech Growth Trust PLC
01 October 2024
The Biotech Growth Trust PLC
Voting Rights and Capital
In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, The Biotech Growth Trust PLC (the "Company") announces the following:
As at 30 September 2024, the Company capital consists of ordinary shares of 25p with each ordinary share holding one voting right. The total number of ordinary shares in issue is 31,963,979. The Company has no ordinary shares in Treasury.
Therefore, the total number of voting rights in the Company is 31,963,979.
The above figure (31,963,979) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in the Company or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
- END -
Frostrow Capital LLP
Company Secretary
Tel: 0203 709 8734
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 27 September 2024 was 1101.50p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
30 September 2024
For immediate release
27 September 2024
THE BIOTECH GROWTH TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 18 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 4,929,790 that a market total of 57,237 Ordinary shares of 25p each in the capital of the Company were purchased today for cancellation by the Company at a price of 1,023.56 pence per share.
Following this transaction, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 31,963,979. The Company does not currently hold any Ordinary shares in treasury.
The figure of 31,963,979 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Katherine Manson
Frostrow Capital LLP
Tel: 020 3709 8734
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 26 September 2024 was 1092.07p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
27 September 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 25 September 2024 was 1087.36p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
26 september 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 24 September 2024 was 1093.36p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
25 September 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 23 September 2024 was 1101.58p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
24 September 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 20 September 2024 was 1139.19p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
23 September 2024
For immediate release
20 September 2024
THE BIOTECH GROWTH TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 18 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 4,929,790 that a market total of 50,000 Ordinary shares of 25p each in the capital of the Company were purchased today for cancellation by the Company at a price of 1,056.53 pence per share.
Following this transaction, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 32,021,216. The Company does not currently hold any Ordinary shares in treasury.
The figure of 32,021,216 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Katherine Manson
Frostrow Capital LLP
Tel: 020 3709 8734
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 19 September 2024 was 1147.97p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
20 September 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 18 September 2024 was 1126.28p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
19 September 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 17 September 2024 was 1127.22p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
18 September 2024
The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.
RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.
Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.
On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.